TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Bio-Works Technologies AB
Closing information (x1000 EUR)
| Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Turnover |
3,713
|
2,142
|
721 |
| Financial expenses |
2
|
2
|
40 |
| Earnings before taxes |
-4,016
|
-916
|
-4,485 |
| EBITDA |
-4,100
|
-893
|
-4,387 |
| Total assets |
8,232
|
11,818
|
4,533 |
| Current assets |
8,014
|
11,644
|
4,374 |
| Current liabilities |
2,150
|
1,208
|
801 |
| Equity capital |
6,083
|
10,610
|
3,732 |
| - share capital |
316
|
341
|
303 |
| Employees (average) |
43
|
32
|
31 |
Financial ratios
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Solvency |
73.9%
|
89.8%
|
82.3% |
| Turnover per employee |
86
|
67
|
23 |
| Profit as a percentage of turnover |
-108.2%
|
-42.8%
|
-622.1% |
| Return on assets (ROA) |
-48.8%
|
-7.7%
|
-98.1% |
| Current ratio |
372.7%
|
963.9%
|
546.1% |
| Return on equity (ROE) |
-66.0%
|
-8.6%
|
-120.2% |
| Change turnover |
1,744
|
1,435
|
165 |
| Change turnover % |
89%
|
203%
|
30% |
| Chg. No. of employees |
11
|
1
|
1 |
| Chg. No. of employees % |
34%
|
3%
|
3% |
Total value of public sale
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.